This brand name is authorized in Nigeria.
The drug IBUKUKA contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
WK2XYI10QM - IBUPROFEN
|
|
Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation. |
|
2
|
UNII
362O9ITL9D - ACETAMINOPHEN
|
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
3
|
UNII
3G6A5W338E - CAFFEINE
|
|
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine's main action is as a CNS stimulant. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-9184 | Capsule | Ibukuka Capsules (check smpc) CAP 200 mg; 325 mg; 30 mg 2 x 10's (in blisters) | Capsule 28 CMS-PP-271460 IBUKUKA CAPSULES PARACETAMOL,IBUPROFEN AND CAFFEINE Paracetamol 325mg, Ibuprofen 200mg, caffeine 30mg, corn starch, gelatin, methyl paraben, propyl paraben, talc, magnesium stearate A4-9184 Drugs Nigerian Products 2X10 capsule OTC 6/27/2022 KCH CONSUMER HEALTHCARE LIMITED, 2B, KWAME NKRUMAH LANE, CROWN ESTATE LEKKI EPE EXPRESSWAY 8032317925 Kchconsumer@gmail.com KCH Consumer Healthcare Ltd., Plot 1-6 KCH Close, Off Atlantic Hall Expressway, Poka, Lekki Free Trade Zone, Epe, Lagos., Nigeria | 25/05/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M01AE51 | Ibuprofen, combinations | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-9184 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.